D. Selchen

发表

Quantitative spinal cord MRI in radiologically isolated syndrome

X. Montalban, M. Hohol, A. Bharatha, 2018, Neurology: Neuroimmunology & Neuroinflammation.

Bilateral medial medullary infarction: a systematic review.

G. Saposnik, D. Selchen, Jitphapa Pongmoragot, 2013, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Atrial fibrillation in patients with cryptogenic stroke.

David J Gladstone, Muhammad Mamdani, Martin O'Donnell, 2014, The New England journal of medicine.

Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data.

Renan Sales Barros, Hester F. Lingsma, Ivo G. H. Jansen, 2018, The Lancet. Neurology.

Safety and Feasibility of Collateral Blood Flow Augmentation After Intravenous Thrombolysis

K. Butcher, D. Emery, P. Schellinger, 2011, Stroke.

Rapid Assessment and Treatment of Transient Ischemic Attacks and Minor Stroke in Canadian Emergency Departments: Time for a Paradigm Shift.

Thalia Shoshana Field, A. Demchuk, D. Gladstone, 2015, Stroke.

Anti-JC Virus Antibody Prevalence in Canadian MS Patients

M. Freedman, A. Zhang, Y. Lapierre, 2014, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

Delirium in Acute Stroke: A Systematic Review and Meta-Analysis

G. Saposnik, D. Selchen, Qiyun Shi, 2012, Stroke.

Delirium in Acute Stroke

G. Saposnik, D. Selchen, Qiyun Shi, 2012 .

Risk for Major Bleeding in Patients Receiving Ticagrelor Compared With Aspirin After Transient Ischemic Attack or Acute Ischemic Stroke in the SOCRATES Study (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes)

Mikhail V. Arkhipov, D. Tanné, C. Anderson, 2017, Circulation.

Expert opinion on the use of cladribine tablets in clinical practice

D. Centonze, X. Montalban, P. Vermersch, 2020, Therapeutic advances in neurological disorders.

In-Patient Code Stroke: A Quality Improvement Strategy to Overcome Knowledge-to-Action Gaps in Response Time

G. Saposnik, R. Nisenbaum, D. Selchen, 2017, Stroke.

Identifying gaps in the management of atrial fibrillation with anticoagulation for stroke prevention (GIANTS): a quality improvement initiative

G. Saposnik, D. Selchen, C. Kassardjian, 2022, Journal of Neurology.

Complement Inhibition in Myasthenia Gravis and Neuromyelitis Optica Spectrum Disorder

M. Freedman, D. Selchen, A. Genge, 2021, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

Prevalence of Fabry Disease and Outcomes in Young Canadian Patients With Cryptogenic Ischemic Cerebrovascular Events

G. Saposnik, D. Selchen, G. Lebovic, 2017, Stroke.

Clinical characteristics and outcomes of multiple sclerosis patients with COVID-19 in Toronto, Canada

Ashley Jones, M. Hohol, D. Rotstein, 2022, Multiple Sclerosis and Related Disorders.

Cognitive impairment, the central vein sign, and paramagnetic rim lesions in RIS

D. Reich, M. Absinta, B. Dewey, 2021, Multiple sclerosis.

Blunt Cerebrovascular Injuries: Diagnosis and Management Outcomes

L. N. de Tilly, D. Selchen, W. Montanera, 2010, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level data

Michael T. McManus, Renan Sales Barros, Hester F. Lingsma, 2019, The Lancet Neurology.

Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practice

D. Centonze, P. Vermersch, P. Sørensen, 2021, medRxiv.

Do all ischemic stroke subtypes benefit from organized inpatient stroke care?

Eric E. Smith, G. Saposnik, G. Saposnik, 2010, Neurology.

Atrial Premature Beats Predict Atrial Fibrillation in Cryptogenic Stroke: Results From the EMBRACE Trial

David J. Gladstone, Muhammad Mamdani, S. Abootalebi, 2015, Stroke.

Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial

D. Arnold, S. Reingold, C. Pozzilli, 2020, The Lancet Neurology.

Treatment Optimization in MS: Canadian MS Working Group Updated Recommendations

Douglas L Arnold, Yves Lapierre, D. Arnold, 2013, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial.

Thalia Shoshana Field, Eric E. Smith, Stacy D. Brown, 2020, The Lancet.

Clinical and MRI characteristics of multiple sclerosis in patients of Middle Eastern and North African ancestry residing in Ontario, Canada

Ashley Jones, Jiwon Oh, S. Baral, 2020, Multiple sclerosis.

Managing Multiple Sclerosis: Treatment Initiation, Modification, and Sequencing

M. Freedman, A. Prat, P. Giacomini, 2018, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

Treatment Optimization in Multiple Sclerosis*

D. Paty, M. Freedman, F. Grand'Maison, 2004, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

Risk factors, inpatient care, and outcomes of pneumonia after ischemic stroke

G. Saposnik, R. Hall, D. Selchen, 2011, Neurology.

Acute central nervous system inflammation following COVID-19 vaccination: An observational cohort study

K. Krysko, R. Schneider, A. Muccilli, 2023, Multiple sclerosis.

Socioeconomic Status, Hospital Volume, and Stroke Fatality in Canada

V. Hachinski, G. Saposnik, A. Baibergenova, 2008, Stroke.

Stroke Unit Care: Does Ischemic Stroke Subtype Matter?

Eric E. Smith, G. Saposnik, D. Selchen, 2011, International journal of stroke : official journal of the International Stroke Society.

Decision making under uncertainty, therapeutic inertia, and physicians’ risk preferences in the management of multiple sclerosis (DIScUTIR MS)

G. Saposnik, D. Prefasi, J. Maurino, 2016, BMC Neurology.

Therapeutic Inertia in Multiple Sclerosis Care: A Study of Canadian Neurologists

X. Montalban, G. Saposnik, Jiwon Oh, 2018, Front. Neurol..

Decision-making in Multiple Sclerosis: The Role of Aversion to Ambiguity for Therapeutic Inertia among Neurologists (DIScUTIR MS)

P. Tobler, C. Ruff, G. Saposnik, 2017, Front. Neurol..

Prevalence of Fabry disease in young patients with cryptogenic ischemic stroke.

L. Gioia, G. Saposnik, D. Selchen, 2013, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Eosinophilic CNS vasculitis can mimic demyelinating disease of the brain and spinal cord

D. Munoz, R. Schneider, D. Selchen, 2014, Journal of Neuroimmunology.

Fabry's Disease: A Prospective Multicenter Cohort Study in Young Adults with Cryptogenic Stroke

M. Mamdani, G. Saposnik, K. Thorpe, 2012, International journal of stroke : official journal of the International Stroke Society.

MS, MRI, and the 2010 McDonald criteria

M. Freedman, David K.B. Li, F. Grand'Maison, 2012, Neurology.

Everything Old is New Again

J. Burneo, S. Morrow, R. Hammond, 2015, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

Expert opinion on the long-term use of cladribine tablets for multiple sclerosis: Systematic literature review of real-world evidence.

D. Centonze, P. Vermersch, E. Celius, 2022, Multiple sclerosis and related disorders.

Posterior cortical dementia with alexia: neurobehavioural, MRI, and PET findings.

R. Kaplan, C. Nahmias, L. Freedman, 1991, Journal of neurology, neurosurgery, and psychiatry.

Treatment experience, burden, and unmet needs (TRIBUNE) in multiple sclerosis: the costs and utilities of MS patients in Canada.

A. Gustavsson, K. Karampampa, D. Selchen, 2012, Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharamcologie clinique.

Switching from Injectable Therapy Leads to High Continuation Rate on Fingolimod (P7.221)

Y. Lapierre, D. Selchen, R. Schecter, 2014 .

Utility of the Canadian Treatment Optimization Recommendations (TOR) in MS Care

A. Traboulsee, M. Freedman, F. Grand'Maison, 2013, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

Recommendations criteria for determining level of concern for patients with changes in relapse , disease progression and MRI outcomes ( adapted with permission from

A. Traboulsee, M. Freedman, F. Grand'Maison, 2013 .

Severe aseptic temporal lobe encephalitis on fingolimod.

D. Rotstein, A. Bharatha, D. Selchen, 2018, Multiple sclerosis and related disorders.

Language discordance as a marker of disparities in cerebrovascular risk and stroke outcomes: A multi-center Canadian study

Ryan T. Muir, P. Austin, N. Herrmann, 2023, Cerebral circulation - cognition and behavior.

Mikhail V. Arkhipov, D. Tanné, C. Anderson, 2017, Circulation.

Michael T. McManus, Renan Sales Barros, Hester F. Lingsma, 2019, The Lancet. Neurology.

Bringing innovation to stroke care: development of a comprehensive stroke unit.

D. Selchen, S. Bisaillon, Nicole Pageau, 2004, Axone.

Socioeconomic Status, Hospital Volume, and Stroke Fatality in Canada

V. Hachinski, G. Saposnik, A. Baibergenova, 2008, Stroke.

Good is not Good Enough: The Benchmark Stroke Door-to-Needle Time Should be 30 Minutes

Dar Dowlatshahi, Richard H. Swartz, Noreen Kamal, 2014, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial.

Thalia Shoshana Field, Eric E. Smith, Stacy D. Brown, 2020, Lancet.